These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 33950524)

  • 21. R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue.
    Chen Y; Pal B; Lindeman GJ; Visvader JE; Smyth GK
    Sci Data; 2022 Mar; 9(1):96. PubMed ID: 35322042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
    Atkinson RL; Yang WT; Rosen DG; Landis MD; Wong H; Lewis MT; Creighton CJ; Sexton KR; Hilsenbeck SG; Sahin AA; Brewster AM; Woodward WA; Chang JC
    Breast Cancer Res; 2013; 15(5):R77. PubMed ID: 24008095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
    BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-cell and spatially resolved atlas of human breast cancers.
    Wu SZ; Al-Eryani G; Roden DL; Junankar S; Harvey K; Andersson A; Thennavan A; Wang C; Torpy JR; Bartonicek N; Wang T; Larsson L; Kaczorowski D; Weisenfeld NI; Uytingco CR; Chew JG; Bent ZW; Chan CL; Gnanasambandapillai V; Dutertre CA; Gluch L; Hui MN; Beith J; Parker A; Robbins E; Segara D; Cooper C; Mak C; Chan B; Warrier S; Ginhoux F; Millar E; Powell JE; Williams SR; Liu XS; O'Toole S; Lim E; Lundeberg J; Perou CM; Swarbrick A
    Nat Genet; 2021 Sep; 53(9):1334-1347. PubMed ID: 34493872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis.
    Nee K; Ma D; Nguyen QH; Pein M; Pervolarakis N; Insua-Rodríguez J; Gong Y; Hernandez G; Alshetaiwi H; Williams J; Rauf M; Dave KR; Boyapati K; Hasnain A; Calderon C; Markaryan A; Edwards R; Lin E; Parajuli R; Zhou P; Nie Q; Shalabi S; LaBarge MA; Kessenbrock K
    Nat Genet; 2023 Apr; 55(4):595-606. PubMed ID: 36914836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models.
    Morello G; Cancila V; La Rosa M; Germano G; Lecis D; Amodio V; Zanardi F; Iannelli F; Greco D; La Paglia L; Fiannaca A; Urso AM; Graziano G; Ferrari F; Pupa SM; Sangaletti S; Chiodoni C; Pruneri G; Bardelli A; Colombo MP; Tripodo C
    Cancer Immunol Res; 2021 Jul; 9(7):825-837. PubMed ID: 33941587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary fat of breast cancer: gene expression profiling and functional characterization.
    Wang F; Gao S; Chen F; Fu Z; Yin H; Lu X; Yu J; Lu C
    PLoS One; 2014; 9(10):e109742. PubMed ID: 25291184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
    Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
    Front Immunol; 2020; 11():563044. PubMed ID: 33250890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonality, Antigen Recognition, and Suppression of CD8
    Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
    Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis.
    Tashireva LA; Denisov EV; Gerashchenko TS; Pautova DN; Buldakov MA; Zavyalova MV; Kzhyshkowska J; Cherdyntseva NV; Perelmuter VM
    Immunobiology; 2017 Apr; 222(4):631-640. PubMed ID: 27916281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
    O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
    Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
    Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer.
    Liu K; Han H; Xiong K; Zhai S; Yang X; Yu X; Chen B; Liu M; Dong Q; Meng H; Gu Y
    J Transl Med; 2024 Aug; 22(1):804. PubMed ID: 39210391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?
    Wang L; Di LJ
    Int J Biol Sci; 2014; 10(5):566-75. PubMed ID: 24910535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
    Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
    Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
    Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
    Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.